Resources|Podcasts|March 28, 2025
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
Author(s)PPD, Thermo Fisher Scientific
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Related Content
Trending on Pharmaceutical Technology
1
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
2
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
3
Six-Month eCOA Timelines Signal Need for Earlier Planning
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5